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Summary 
Background: Palmar osteochondral disease (POD) is a common cause of lameness in competition 
horses. Magnetic resonance imaging (MRI) is the most sensitive diagnostic modality currently available, 
however it may not be financially nor logistically practical for routine screening of POD. There is increasing 
interest in the use of metabolomics for diagnosis prior to progression to irreversible damage. 
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Objectives: To determine metabolite levels in synovial fluid (SF) of horses with a clinical diagnosis of POD 
based on diagnostic analgesia and MRI, with the hypothesis that metabolomic profiles differ between 
diseased and healthy joints. 
Study design: Prospective clinical study.
Methods: Synovial fluid was collected from metacarpo/tarsophalangeal joints (MC/TPJ) of 29 horses (n = 
51 joints), including 14 controls (n = 26) and 15 cases (n = 25), the latter with lameness localised to the 
MC/TPJ and MR changes consistent with POD (n = 23). Spectra were produced using 1H-nuclear magnetic 
resonance (NMR) spectroscopy and analysed.
Results: Twenty-five metabolites were recognised associated with various biosynthetic and degradation 
pathways. The metabolite abundances within the controls demonstrated increased variability compared 
with the clinical group. The low level of variance between the spectra of the two groups was explained by 5 
principal components. Cross-validation of the cohort demonstrated modest separation of predictive power 
(R2 = 0.67; Q2 = 0.34). Although statistical significance was not achieved, the most influential metabolites 
were glucose and lactate.
Main limitations: The modest sample size and variation in signalment, background and presenting 
condition of the controls may have impacted the discriminative power of the constructed models. The lack 
of matched controls, differences in time of fluid collection and freezing times may have also reduced 
accuracy when representing metabolite profiles.  
Conclusions: This study identified and quantified metabolites present in MC/TPJ SF of clinical cases with 
POD. 
Introduction 
Palmar osteochondral disease (POD) is an important cause of lameness and wastage in competition 
horses. Lesions have been identified in 55-80.4% of all Thoroughbred (TB) racehorses in at least one 
metacarpal/metatarsal (MC/T) condyle, with 14% reporting severe disease [1-4]. Subchondral bone (SCB) 
inflammation in the palmar/plantar apical region of MC/TIII bones occurs due to traumatic injury and chronic 
overloading in bones repeatedly exposed to fast work. The resultant sclerosis, necrosis and cartilage 
thinning weakens the bone making it less capable of withstanding stresses associated with training and 
racing [5]. This eventually leads to focal resorption and formation of a void in the cartilage, followed by 
collapse of the articular surface, at which point the overlying articular cartilage is no longer viable. Early 
recognition of the condition is therefore vital to facilitate prompt treatment and/or management changes.
Advanced imaging is required for diagnosis prior to manifestation of irreversible damage, making early 
identification, monitoring and prognostication a challenge for many ambulatory veterinarians for which 
access to these imaging modalities may not be readily available. Magnetic resonance imaging (MRI) 
accurately represents cartilage and SCB density and thickness [6] and has been validated for detection of 
lesions in the metacarpal/tarsophalangeal joint (MC/TPJ) [2,7-10], however some abnormal MRI findings A
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consistently recognised with POD are seen in normal horses in training and additional diagnostic methods 
are therefore required to facilitate early detection. 
Metabolomics is a powerful systems biological approach that simultaneously measures all metabolites 
present within biological fluids or tissues [11]. Metabolite phenotypic profiling captures relationships of the 
cellular processes they represent. It provides multi-dimensional information on biochemical responses of 
complex systems to a range of intrinsic and environmental stimuli under specific circumstances [12-14], 
with the ultimate aim of serving as unique ‘fingerprints’ or disease biomarkers in named pathological states. 
Compared with other biochemical techniques, metabolomics requires minimal pre-treatment and 
processing and has been used successfully in the rapid assessment of numerous systemic disease states 
in human and veterinary medicine [15-20]. Metabolites within synovial fluid (SF) accurately represent 
activity of the surrounding synovial tissues, bones and cartilage [14] and recent equine studies report 
successful differentiation of osteoarthritis [21], osteochondrosis [22] and joint sepsis [20]. 
The aim of this study was to investigate equine SF metabolomics from samples collected in a clinical 
environment and to identify potential metabolite biomarkers in cases with MRI-diagnosed POD, with the 
hypothesis being metabolomic profiles are different between diseased and healthy joints.
Materials and Methods
Clinical cases were recruited from horses presenting to the Royal (Dick) School of Veterinary Studies 
Equine Hospital for lameness investigation between January 2015 and March 2018 and consisted 
predominantly of Thoroughbred racehorses in training from one racing yard. Criteria for inclusion were: 1) 
lameness localised to the MC/TPJ based on regional or intra-articular analgesia; 2) absence of other 
causative lesions within the joint on comprehensive radiographic examination; 3) MRI changes consistent 
with those described for POD [2]. Inclusion criteria for control horses were: 1) clinical presentation for 
unrelated conditions or lameness that did not improve upon intra-articular analgesia of the MC/TPJ; 2) 
absence of pathology on subsequent MRI of the MC/TPJ. Some of the control cases necessitated 
euthanasia for humane reasons due to the initial presenting conditions. 
Magnetic Resonance Imaging
The MRI scans were obtained under standing sedation using a 0.27-Tesla dedicated and fully calibrated 
equine MRI systema. T1 and T2-weighted gradient echo (GRE) and short tau inversion recovery (STIR) 
GRE sequences were acquired in transverse, dorsal and sagittal planes. High resolution scans were 
acquired wherever possible and some sequences used live-motion correction techniques [2]. The scans 
were blindly reviewed using an open-source DICOM viewerb by two equine clinicians, one of whom was 
experienced in interpretation of low-field MR images (S.E.T). The medial and lateral condyles of the MC/TIII 
bones were assessed using a POD score adapted from Olive et al. [23] and based mainly on T1 and T2-
weighted images, with STIR included where available. Briefly, grade 0 described normal SCB, grade 1 mild A
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sclerosis, grade 2 moderate to marked sclerosis, grade 3 SCB resorption and grade 4 subchondral collapse 
or fragmentation. The presence of subchondral bone marrow lesions was marked with an asterisk (*). The 
same sequence of scans was carried out on the distal limbs of control cases. In those requiring euthanasia, 
scans were performed within 12 hours of death.  
Sample collection
Synovial fluid was aspirated from the affected MC/TPJ at the time of intra-articular analgesia or medication 
or within 10 minutes of euthanasia of those euthanased. One ml of SF was placed into uncoated 1.5 ml 
collection tubes and the sample centrifuged at 1600 g for 5 minutes at room temperature to remove 
particulate matter prior to transfer of the cell-free supernatant into a clean collection tube. This was snap-
frozen using liquid nitrogen and stored at -80C for a maximum freezing time of 8 months.
Sample preparation
The samples were thawed over ice and 300 μl of SF suspended in a buffer solution containing 50%(v/v) 
SF, 40%(v/v) deuterium oxide (18.2MΩ), 10%(v/v) 1M sodium phosphate pH 7.4 bufferd and 0.0025%(v/v) 
sodium azidee. The samples were vortexed for one minute and centrifuged at 13000 g at 4°C for 2 minutes 
prior to transfer of 590 μL into 5-mm outer diameter NMR tubes.
NMR acquisition and spectra processing
One dimensional (1D) 1H-NMR spectra with Carr-Purcell-Meiboom-Gill (CPMG) filter was acquired using a 
700-MHz Bruker Avance-III spectrometer with a TCI cryoprobe and chilled Sample-Jet autosampler. 
Standard vendor-supplied pulse sequences (noesypr1d and cpmgpr1d) were used for statistical analysis. 
The spectra were acquired at 36.8°C with a 4-second interscan delay, 32 transients and 15-ppm spectral 
width using Topsin 3.1 and IconNMR 4.6.7. Results were processed with automated phasing, baseline 
correction and a standard vendor-processing routine. The spectra were measured in a proton NMR 
spectroscopy lock mode using deuterium oxide as internal lock. The left signal of the alpha-glucose 
anomeric doublet was aligned to 5.244 ppm. 
Metabolite annotation and identification
The results were evaluated visually and all spectra scrutinised prior to inclusion in statistical analysis to 
ensure community-recommended quality control criteria were met [24].  This included consistent line-
widths, a flat baseline and water suppression to a signal of less than 0.4 ppm wide. Spectra that met the 
criteria were divided into regions (‘buckets’) and metabolites annotated from Chenomx NMR 330-
mammalian metabolite library. Each bucket was labelled with the metabolite peak identity from the pattern 
file. Buckets attributed to ethanol were omitted for multivariate analysis. Identities were confirmed by a 
combination of 1H 1D-NMR and, where possible, in-house two-dimensional (2D) 1H13C Heteronuclear 
Single Quantum Coherence NMR standards.  As not all 1H NMR spectra were acquired at the same time, 
spectra were assessed for batch effect between runs using iconNMR and MetaboAnalyst.A
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Data analysis
The spectra were divided into two groups (POD and control) and analysed using MetaboAnalyst 4. The 
‘bucketed’ data was normalised to the median to improve statistical reliability and reduce any systemic bias 
arising from sampling inconsistencies. Pareto-scaling was carried out for multivariate analysis. Univariate 
analysis was performed using t-tests with application of a False-Discovery Rate (FDR) adjusted P-value of 
0.05. Multivariate analysis included unsupervised Principal Component Analysis (PCA) and Partial Least 
Squares Discriminant Analysis (PLS-DA) to determine the optimal number of components for the model.  
Statistical significance was set at P≤0.05 following correction for multiple testing using the Benjamini-
Hochberg FDR method. Quantile and PCA plots were generated by standard analytical routines using the 
software package ‘R’.
Results
A total of 79 MC/TPJ met the inclusion criteria (clinical 30; controls 49) and spectra from 51 samples (29 
horses) met quality control criteria (clinical 25; controls 26) (Table 1). The remainder were excluded due to 
processing inconsistencies resulting in analog-to-digital converter overflow. 
 
Magnetic Resonance Imaging
In total, 20 condyles were graded as grade 1, 14 as grade 2 and 8 as grade 3, with 11 cases demonstrating 
concurrent bone marrow lesions (Figs 1 and 2). No grade 4 lesions were noted. Three condyles showed no 
evidence of POD and one condyle demonstrated a fissure fracture. All control joints had a POD score of 0. 
The results are detailed in Supplementary Item 1.
Metabolomics
The NMR spectra for both groups demonstrated a consistent set of metabolite signals and all signals were 
well-matched. Following division of the NMR spectral extracts into individual spectral bins accounting for 
one or more multiplets, 139 metabolite signals were detected in each extract. Of these, 107 (78.7%) were 
annotated to 48 metabolites and identification confirmed for 25 using an in-house library and reported with 
their Metabolomics Standards Initiative level [24] (Table 2). Buckets with values missing following 
processing were randomly distributed across the dataset. The spectra from the sample from the joint with 
the fissure fracture was analysed separately and although no quantifiable differences were identified, the 
sample was not included in the general analysis. No batch effect was observed between spectra acquired 
at different times and thus batch correction was not required.
The metabolite abundances within the POD group demonstrated lower variability compared with the control 
group. Within the control group, eight samples from non-Thoroughbred cases were set apart from the 
general cluster however univariate analysis showed the differences in levels of specific metabolites within 
these samples did not reach statistical significance. Multivariate analysis using unsupervised PCA A
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demonstrated minimal variance to be present between the spectra of the POD and control groups and 
statistical significance was not met (Fig 3). Ninety-five percent of this variance was explained by five 
principal components (PC), with PC1 and PC2 explaining 58.2% of variance. Supervised multivariate 
discriminate analysis using PLS-DA plots of the known metabolites identified the optimal model comprising 
two components and demonstrating moderate predictive power (R2 = 0.67, Q2 = 0.34) (Fig 4). The most 
influential metabolites were glucose and lactate, with decreased levels seen in POD cases (Fig 5).  
Discussion
This study used metabolomics to analyse SF collected in a clinical setting from horses with POD. Although 
no significantly differentiating metabolites were identified, reduced concentrations of glucose and lactate 
were found in clinical cases. Signal alterations of specific metabolites are identified in sclerotic SCB and 
thought to reflect hypoxic intra-cellular conditions [25]. Cartilage damage induces a local pathologic 
inflammatory response that perpetuates a cycle of cartilage destruction and progressive joint injury [26]. 
Additionally, proliferation of inflammatory cells in synovitis will increase the metabolic state within the joint 
[27]. Upregulation of the glucose transporter GLUT-1 occurs in hypoxic environments [28] and 
chondrocytes from human patients with osteoarthritis switch from oxidative phosphorylation to anaerobic 
glycolysis in order to provide energy for proinflammatory pathways [29]. We hypothesise a similar scenario 
occurs in POD, thereby explaining the reduced glucose levels in SF seen in clinical cases. Reduced levels 
of lactate were unexpected, as lactate has been previously demonstrated to accumulate in hypoxic 
environments following conversion of pyruvate into lactate by lactate dehydrogenase in the absence of 
oxygen [27]. This finding may potentially be related to the fact sampling of controls was performed post-
mortem in the majority of cases (Table 1), which may have resulted in the increased lactate levels seen in 
the controls relative to clinical cases. Although all samples were collected without delay following 
euthanasia in an attempt to minimise post-mortem changes, the authors acknowledge the potential exists 
for metabolites to be altered from their normal state due to hypoxia [18]. Consequently, there is a need to 
undertake future studies including only ante-mortem samples of both cases and controls in order to confirm 
the significance, if any, of this finding. In addition, although MRI is an accurate representation of cartilage 
and SCB density [6], gross and histological examination of the condyles would have improved accuracy of 
grading of disease severity [1,33] however this was not possible given the design of the study.
One main limitation of the study was the low number of samples that produced quantifiable spectra. It is 
challenging to establish appropriate numbers required for metabolomic studies due to large numbers of 
variables present. However, all previous equine metabolomics studies have included similarly moderate 
numbers. The current model has demonstrated that differences exist in signal strength of a number of 
metabolites between the two groups. Increased variance between groups is expected with larger cohorts 
and stronger models with greater R2 and Q2 values. This larger variance is expected to improve sensitivity 
in the identification of specific metabolites with differing levels between the two cohorts. One example of A
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this includes the up-regulation of taurine metabolism, which was demonstrated in sclerotic SCB in a 
previous study [25]. 
Compared to other forms of ‘omics’ technology, NMR spectroscopy requires less sample preparation and 
can generate a comprehensive metabolic profile from intact biofluids and tissues [30]. It is therefore 
preferred for analysis of native samples as it may be conducted in subclinical settings with high throughput 
[31]. Between cohorts of the same breed, low variations are reported in the metabolic phenotypes and 
metabolic uniformity is seen despite differing ages, environment and fitness levels [11]. Escalona et al. [11] 
hypothesised these findings to be due to the relatively homogenous genetic and environmental 
backgrounds of the TB breed. This is consistent with previous mammalian studies [32] and evidenced in 
the current study by the increased variability of metabolite abundances demonstrated between controls 
compared with the POD group, the latter of which consisted predominantly of TB racehorses from a single 
yard that were managed in a similar manner. This was another significant limitation of the study, as the 
difficulty in acquiring an adequate number of breed-matched control cases meant the control group 
included samples from horses that varied in signalment, background and presenting conditions. As 
metabolomes are affected not only by disease processes but also other intrinsic and extrinsic influencers, 
results of future studies would be strengthened significantly by the inclusion of breed-matched controls. 
We recognised that freezer-storage time had the potential to affect cell-processing pathways and negatively 
influence metabolite profiles, hence the reason batch effect was examined in case any significant systemic 
variations existed in samples stored for different lengths of time prior to processing. However, batch testing 
revealed the time of spectra acquisition had no impact on the results. In our experience, samples may be 
stored for up to 12 months without affecting metabolomic profiles, which is similar to the negligible impact 
that long-term storage at -80°C appears to have on serum samples [34]. 
Ethanol is a recognised contaminant resulting from surgical disinfectant of the synoviocentesis site [20] and 
although acknowledged as the end-product of several known metabolic pathways and drug metabolism, in 
the authors’ experience is rarely identified as a native metabolite in mammals and may in fact negatively 
represent profiles. As a result, the ‘buckets' attributed to the ethanol peak were omitted for multivariate 
analysis. 
One-dimensional NMR is the industry standard for statistical analysis however does result in some 
overlapping of the signals from the metabolites. Two-dimensional NMR, which includes the naturally 
occurring 13C, separates these signals and is therefore useful for confirmation of the identity of specific 
metabolites, although the ability to quantify results is reduced.  Increased utilisation of 2D-NMR technology 
and a greater number of in-house standards would therefore improve confidence of metabolite recognition 
and facilitate identification of the remaining unidentified metabolites.  In addition, proteomics should be A
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considered in future POD SF studies as proteins are more stable and robust and therefore less sensitive to 
processing inconsistencies. 
The use of metabolomics to analyse SF is a relatively novel concept in equine medicine and this study 
confirmed its applicability in analysis of samples collected in a clinical environment. In addition, the study 
provides baseline metabolomic information for future research into POD and other similar degenerative 
joint diseases. Although no metabolite abundances were statistically different between POD and control 
groups, there were patterns of change in certain metabolites which warrant further investigation to 
determine if metabolic fingerprints can be identified with higher numbers. Further validation is required with 
a larger sample set and matched controls obtained under the same circumstances to confirm candidate 
markers. A panel of biomarkers has more strength to discriminate a disease process than a single 
metabolite. Establishment of one such panel would improve diagnostic capacity and allow treatment and 
management changes may be put into place to halt or slow progression of the disease. 
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Tables
Table 1: Further details of clinical and control cases. 
CLINICAL CASES CONTROLS
Number of cases 15 horses (14 TB) 14 horses (10 TB)
Median age (range) 7 (4-10) TB 7 (4-20)
Others 5 (5-15)
Number of samples 25 26
Limbs involved LF 2
RF 3
LF RF 14
RH 6
LF 3
RF 1
LF RF 20
RH 2
Time of synoviocentesis AM 25 AM 8
PM 18
TB = Thoroughbred; LF = left fore; RF = right fore; RH = right hind; AM = ante-mortem; PM = post-mortem
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved
Table 2: Metabolites identified and annotated by Chenomx.
Database identifier Metabolite Identification Reliability
HMDB00357 3-Hydroxybutyrate MS Level 2
HMDB01149 5-Aminolevulinate MS Level 2
HMDB00042 Acetate MS Level 1
HMDB00060 Acetoacetate MS Level 2
HMDB00094 Citrate MS Level 1
HMDB00064 Creatine MS Level 1
HMDB00562 Creatinine MS Level 1
HMDB00112 D-Glucose MS Level 1
HMDB00108 Ethanol MS Level 1
HMDB00142 Formate MS Level 2
HMDB00663 Glucarate MS Level 2
HMDB00131 Glycerol MS Level 1
HMDB00123 Glycine MS Level 1
HMDB00128 Guanidoacetate MS Level 2
HMDB00190 Lactate MS Level 1
HMDB00161 L-Alanine MS Level 1
HMDB00062 L-Carnitine MS Level 2
HMDB00641 L-Glutamine MS Level 1
HMDB00177 L-Histidine MS Level 1
HMDB00687 L-Leucine MS Level 1
HMDB00159 L-Phenylalanine MS Level 1
HMDB00167 L-Threonine MS Level 2
HMDB00158 L-Tyrosine MS Level 1A
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Database identifier Metabolite Identification Reliability
HMDB00883 L-Valine MS Level 1
HMDB00243 Pyruvate MS Level 1
MS = metabolomics standard
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Figure legends
Fig 1: T1 (left) and T2-weighted (right) MRI images demonstrating POD scores of 2 (moderate sclerosis) 
and 3* (SCB resorption with bone marrow involvement) in the lateral and medial condyles respectively. 
Lateral is to the left of the image.
Fig 2: Frontal STIR MRI image demonstrating a POD lesion with increased fluid signal in the lateral 
condyle. Lateral is to the left of the image. 
Fig 3: Unsupervised PCA scores plot of POD (green) and control (red) samples demonstrating minimal 
variance between groups. Shading represents 95% confidence region.
Fig 4: Supervised PLS-DA scores plot showing POD and control groups with the two components 
demonstrating best fit of the model (R2 = 0.67, Q2 = 0.34).
Fig 5: VIP scores for the 25 most influential buckets of PLS-DA decreased levels of glucose and lactate in 
the POD group were not statistically significant between groups.
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Supporting Information
Supplementary Item 1: Lesion grading using the POD scoring system adapted from Olive et al. [23]
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